Eric Adam Pierce MD PhD
Retinal Disease
Solman and Libe Friedman Professor of Ophthalmology, Director Ocular Genomics Institute, Mass Eye and Ear, Harvard Medical School
Join to View Full Profile
243 Charles St# MassachuBoston, MA 02114
Phone+1 617-573-3621
Fax+1 617-573-3661
Dr. Pierce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children's Hospital1994 - 1996
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1991 - 1994
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1990 - 1991
Harvard Medical SchoolClass of 1990
University of Wisconsin - MadisonPhD, Biochemistry, 1981 - 1986
Certifications & Licensure
MA State Medical License 1994 - 2026
PA State Medical License 1999 - 2012
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Ephraim Friedman Lecturer in Ophthalmology Mass Eye and Ear, Harvard Medical School
- Richard Weleber Lecturer in Ophthalmology Casey Eye Institute, Oregon Health Sciences University
- Roger Johnson Lecturer in Ophthalmology Children's Hospital and Regional Medical Center, Seattle, Washington
- Join now to see all
Publications & Presentations
PubMed
- Systematic empirical evaluation of individual base editing targets: Validating therapeutic targets in USH2A and comparison of methods.Yuki Tachida, Kannan V Manian, Rossano Butcher, Jonathan M Levy, Nachiket Pendse
Molecular Therapy. 2025-04-02 - Identification of IDH3G, encoding the gamma subunit of mitochondrial isocitrate dehydrogenase, as a novel candidate gene for X-linked retinitis pigmentosa.Lorenzo Bianco, Julien Navarro, Christelle Michiels, Riccardo Sangermano, Christel Condroyer
Genetics in Medicine. 2025-03-19 - Biallelic null variants in C19orf44 cause a unique late onset retinal dystrophy phenotype characterized by patchy perifoveal chorioretinal atrophy.Miriam Ehrenberg, Maayan Avraham, Sandeep Sarma Asodu, Abigail R Moye, Riccardo Sangermano
Genetics in Medicine. 2025-03-10
Journal Articles
- Contribution of Noncoding Pathogenic Variants to RPGRIP1-Mediated Inherited Retinal DegenerationKari E Branham, Emily M Place, Eric A Pierce, Nature
Press Mentions
Investigating CRISPR Treatment for BlindnessAugust 1st, 2024- Gene Therapy Improves Vision in People with Inherited BlindnessMay 6th, 2024
- Experimental Gene Therapy Restores Some Vision in Patients with Inherited Blindness | CNNMay 6th, 2024
- Join now to see all
Grant Support
- The Pathogenesis Of RNA Splicing Factor RPNational Eye Institute2011–2012
- The Pathogenesis Of RNA Splicing Factor RPNational Eye Institute2011
- Novel Photoreceptor Cilia Proteins And Retinal DegenerationsNational Eye Institute2011
- Novel Photoreceptor Cilia Proteins And Retinal DegenerationsNational Eye Institute2009–2011
- A Novel Photoreceptor Protein And Retinal DegenerationsNational Eye Institute2004–2008
- Novel Photoreceptor Protein And Retinal DegenerationsNational Eye Institute1999–2003
- Animals With Targeted Mutations In Photoreceptor GenesNational Eye Institute2001–2002
- Biochemical Basis Of Retinal NeovascularizationNational Eye Institute1994–1998
Professional Memberships
- American Society of Human GeneticsMember
- Association for Research in Vision and OphthalmologyMember
Other Languages
- Spanish
External Links
- Ocular Genomics Institutehttps://oculargenomics.meei.harvard.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
